share_log

CompuMed Announces Approval and Amendment to Reduce Authorized Shares

CompuMed Announces Approval and Amendment to Reduce Authorized Shares

CompuMed 宣佈批准和修正案以減少授權股份
Accesswire ·  2023/05/25 17:35

LOS ANGELES, CA / ACCESSWIRE / May 25, 2023 / CompuMed, Inc. (OTC PINK:CMPD), a leader in providing diagnostic telemedicine has amended its certificate of incorporation to reduce the number of authorized shares from Twenty Million (20,000,000) to Five Million (5,000,000). The corporation made this change to save on annual franchise fees charged by Delaware, its state of incorporation. The amendment was approved by the board of directors and the corporation obtained written consents from stockholders holding in excess of half of the 1,678,707 shares of common stock currently outstanding to effectuate the reduction in the number of shares authorized for issuance.

加利福尼亞州洛杉磯/ACCESSWIRE/2023年5月25日/提供遠端診斷醫療的領先企業CompuMed公司(場外交易市場代碼:CMPD)修改了其公司註冊證書,將授權股票的數量從2000萬股(2000萬股)減少到500萬股(500萬股)。該公司做出這一改變是為了節省其註冊州特拉華州收取的年度特許經營費。該修正案得到了董事會的批准,公司獲得了持有目前已發行普通股1,678,707股中超過一半的股東的書面同意,以實現減少授權發行的股份數量。

Inquiries regarding this can be sent to investorrelations@compumedinc.com or call 310-258-5002.

有關這方面的查詢,請發送至InvestorRelationship@Compumedinc.com或致電310-258-5002。

About CompuMed, Inc.

CompuMed公司簡介

CompuMed, Inc. (OTCPink: CMPD) Diagnostic Telemedicine services provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world. The Corporation has been in business for over 26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at .

CompuMed公司(OTCPINK:CMPD)診斷遠端醫療服務以更低的成本為患者提供最高水準的臨床護理。它的遠端心血管學和遠端放射學產品通過基於雲的技術和集成的醫療設備向世界任何地方的醫療機構提供即時訪問美國委員會認證的專家。該公司已有26年的業務歷史,為超過1,000個臨床機構提供服務。CompuMed的總部設在加利福尼亞州洛杉磯。請訪問CompuMed網站。

Forward-Looking Statements

前瞻性陳述

Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all passages containing words such as "will," "aims," "anticipates," "becoming," "believes," "continue," "estimates," "expects," "future," "intends," "plans," "predicts," "projects," "targets," or "upcoming." Forward-looking statements also include any other passages that are primarily relevant to expected future events or that can only be evaluated by events that will occur in the future. Forward-looking statements are based on the opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated or implied in the forward-looking statements. Factors that could cause actual results to vary from current expectations and forward-looking statements contained in this press release include, but are not limited to: the timing and volume of business activity from our clients and our ability to continue to provide products and services to such clients; the loss of, or reduction of business from, material clients; our liquidity and cash position; changes in technology; our ability to protect the Corporation's net operating losses and tax benefits; volatility and changes in our stock price, corporate or other market conditions; changes in government regulations or economic conditions; the impact of increased competition and pricing; capacity and supply chain constraints or difficulties; and other factors contained in the Corporation's filings posted on the OTC Markets website. All such forward-looking statements are expressly qualified by these cautionary statements. The Corporation expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.

本新聞稿中的某些陳述屬於“1995年私人證券訴訟改革法案”所指的“前瞻性陳述”。前瞻性陳述包括包含“將”、“目標”、“預期”、“成為”、“相信”、“繼續”、“估計”、“預期”、“未來”、“打算”、“計劃”、“預測”、“專案”、“目標”或“即將到來”等詞語的所有段落。前瞻性陳述還包括主要與預期的未來事件相關或只能通過未來發生的事件進行評估的任何其他段落。前瞻性陳述以作出陳述時管理層的意見和估計為基礎,會受到某些風險和不確定因素的影響,這些風險和不確定性可能會導致實際結果與前瞻性陳述中預期或暗示的結果大不相同。本新聞稿中包含的可能導致實際結果與當前預期和前瞻性陳述不同的因素包括但不限於:我們客戶開展業務活動的時間和數量,以及我們繼續向此類客戶提供產品和服務的能力;重要客戶業務的損失或減少;我們的流動資金和現金狀況;技術的變化;我們保護公司淨運營虧損和稅收優惠的能力;我們的股票價格、公司或其他市場狀況的波動和變化;政府法規或經濟狀況的變化;競爭加劇和定價增加的影響;產能和供應鏈限制或困難;以及公司在場外交易市場網站上公佈的檔案中包含的其他因素。所有這些前瞻性陳述都明確地受到這些警告性聲明的限制。除法律要求外,公司明確不承擔任何義務或承諾公開發布對任何前瞻性陳述的任何更新或修訂,以反映任何此類陳述在本新聞稿日期後所依據的事件、條件或情況。

SOURCE: CompuMed, Inc.

資料來源:CompuMed公司


View source version on accesswire.com:
在accesswire.com上查看源代碼版本:

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論